De Vincentis S, Evangelisti S, Rossi B, Decaroli M, Locaso M, Ansaloni A
Endocrine. 2024; 87(3):1257-1266.
PMID: 39630327
DOI: 10.1007/s12020-024-04124-4.
OuYang Q, Li Y, Xu A, Zhang N, Chen S, Zhou D
Orphanet J Rare Dis. 2024; 19(1):429.
PMID: 39563390
PMC: 11575201.
DOI: 10.1186/s13023-024-03439-9.
Top A, Vanmierlo B, Decramer A
J Orthop Case Rep. 2024; 14(8):6-9.
PMID: 39157504
PMC: 11327683.
DOI: 10.13107/jocr.2024.v14.i08.4626.
Thornton J, Koc Z, Sollars V, Valentovic M, Denvir J, Wilkinson 4th J
Int J Mol Sci. 2024; 25(15).
PMID: 39125916
PMC: 11312970.
DOI: 10.3390/ijms25158344.
Bozadjieva-Kramer N, Shin J, Blok N, Jain C, Das N, Polex-Wolf J
Endocrinology. 2024; 165(9).
PMID: 39045670
PMC: 11311705.
DOI: 10.1210/endocr/bqae090.
The Puzzle of Aspirin and Iron Deficiency: The Vital Missing Link of the Iron-Chelating Metabolites.
Kontoghiorghes G
Int J Mol Sci. 2024; 25(10).
PMID: 38791185
PMC: 11121054.
DOI: 10.3390/ijms25105150.
The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency.
Kontoghiorghes G
Int J Mol Sci. 2024; 25(9).
PMID: 38731873
PMC: 11083551.
DOI: 10.3390/ijms25094654.
A genome-wide association study provides insights into the genetic etiology of 57 essential and non-essential trace elements in humans.
Moksnes M, Hansen A, Wolford B, Thomas L, Rasheed H, Simic A
Commun Biol. 2024; 7(1):432.
PMID: 38594418
PMC: 11004147.
DOI: 10.1038/s42003-024-06101-z.
A Review of New Concepts in Iron Overload.
Sohal A, Kowdley K
Gastroenterol Hepatol (N Y). 2024; 20(2):98-107.
PMID: 38414914
PMC: 10895914.
A Rare Case of Heterozygous C282Y Mutation Causing Hereditary Hemochromatosis With Acute Pancreatitis.
Tonna R, Haddadin R, Iqbal H, Gemil H
Cureus. 2024; 16(1):e52584.
PMID: 38371159
PMC: 10874645.
DOI: 10.7759/cureus.52584.
Understanding How Minerals Contribute to Optimal Immune Function.
Stefanache A, Lungu I, Butnariu I, Calin G, Gutu C, Marcu C
J Immunol Res. 2023; 2023:3355733.
PMID: 37946846
PMC: 10632063.
DOI: 10.1155/2023/3355733.
Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications.
Kontoghiorghes G
Int J Mol Sci. 2023; 24(16).
PMID: 37629109
PMC: 10454416.
DOI: 10.3390/ijms241612928.
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases.
Espina S, Casas-Deza D, Bernal-Monterde V, Domper-Arnal M, Garcia-Mateo S, Lue A
Nutrients. 2023; 15(15).
PMID: 37571424
PMC: 10421025.
DOI: 10.3390/nu15153487.
The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases.
Kontoghiorghes G
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513928
PMC: 10384919.
DOI: 10.3390/ph16071016.
Ferroptosis as an emerging therapeutic target in liver diseases.
Lu Y, Hu J, Chen L, Li S, Yuan M, Tian X
Front Pharmacol. 2023; 14:1196287.
PMID: 37256232
PMC: 10225528.
DOI: 10.3389/fphar.2023.1196287.
Hereditary hemochromatosis with homozygous C282Y HFE mutation: possible clinical model to assess effects of elevated reactive oxygen species on the development of cardiovascular disease.
Shizukuda Y, Rosing D
Mol Cell Biochem. 2023; 479(3):617-627.
PMID: 37133674
DOI: 10.1007/s11010-023-04726-y.
Clinical and Forensic Signs Resulting from Exposure to Heavy Metals and Other Chemical Elements of the Periodic Table.
de Carvalho Machado C, Dinis-Oliveira R
J Clin Med. 2023; 12(7).
PMID: 37048674
PMC: 10095087.
DOI: 10.3390/jcm12072591.
Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.
Kontoghiorghes G
Int J Mol Sci. 2023; 24(5).
PMID: 36902402
PMC: 10002863.
DOI: 10.3390/ijms24054970.
Quantitative MRI of diffuse liver diseases: techniques and tissue-mimicking phantoms.
Tipirneni-Sajja A, Brasher S, Shrestha U, Johnson H, Morin C, Satapathy S
MAGMA. 2022; 36(4):529-551.
PMID: 36515810
DOI: 10.1007/s10334-022-01053-z.
Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.
Haider M, Al Sbihi A, Chaudhary A, Haider S, Edhi A
World J Hepatol. 2022; 14(9):1804-1816.
PMID: 36185720
PMC: 9521447.
DOI: 10.4254/wjh.v14.i9.1804.
